-transparent.png){kind=logo}
The human erythrocyte contains two types of cyclic AMP-dependent protein kinase. The membrane-associated protein kinase holoenzyme can be released intact by hypotonic treatment at alkaline pH. Chromatography on DEAE-cellulose and molecular weight determinations demonstrate that this enzyme is a type I cyclic AMP-dependent protein kinase, while the predominant cyclic AMP-dependent protein kinase found in the cytoplasm is type II. The catalytic subunits of the two types of kinase found in the erythrocyte are identical, but the regulatory subunits, which distinguish the two types of kinase, determine their localization within the cell. It is proposed that the regulatory subunit of the type I enzyme, in addition to binding the catalytic subunit, interacts specifically with one or more membrane proteins and that this interaction may serve to position the kinase in preferential proximity to protein substrates.
G Dreyfuss, and
K J Schwartz, and
E R Blout
January 1975,
Naunyn-Schmiedeberg's archives of pharmacology,
G Dreyfuss, and
K J Schwartz, and
E R Blout
January 1978,
Advances in cyclic nucleotide research,
G Dreyfuss, and
K J Schwartz, and
E R Blout
May 1978,
National Cancer Institute monograph,
G Dreyfuss, and
K J Schwartz, and
E R Blout
July 1986,
Proceedings of the National Academy of Sciences of the United States of America,
G Dreyfuss, and
K J Schwartz, and
E R Blout
January 1974,
Methods in enzymology,
G Dreyfuss, and
K J Schwartz, and
E R Blout
January 1981,
Current topics in cellular regulation,
G Dreyfuss, and
K J Schwartz, and
E R Blout
January 1980,
Annual review of pharmacology and toxicology,
G Dreyfuss, and
K J Schwartz, and
E R Blout
April 1998,
Journal of cell science,
G Dreyfuss, and
K J Schwartz, and
E R Blout
September 1972,
Biochemical and biophysical research communications,
G Dreyfuss, and
K J Schwartz, and
E R Blout
September 1997,
British journal of pharmacology,
